14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
AKTX vs PRTO: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Akari Therapeutics plc (AKTX) is the stronger overall head-to-head candidate over PRTO (PRTO) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 2–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). AKTX carries a Unified Composite Score of 50.1/100 (HOLD) at $7.18 (N/M Forward P/E, 0.0% operating margin), whereas PRTO carries 33.3/100 (SELL) at $24.45 (N/M Forward P/E, N/A operating margin).
Technical & Structure Timing Caution: AKTX trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 47.3); meanwhile PRTO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 22.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AKTX vs PRTO. Trailing 12-month operating profitability (AKTX 0.0% vs PRTO N/A) and valuation multiples (AKTX N/M vs PRTO N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ AKTX vs PRTO Key Questions & Quantitative Answers
As of Nov 20, 2026, Akari Therapeutics plc (AKTX) is the stronger overall head-to-head candidate over PRTO (PRTO) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 2–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). AKTX carries a Unified Composite Score of 50.1/100 (HOLD) at $7.18 (N/M Forward P/E, 0.0% operating margin), whereas PRTO carries 33.3/100 (SELL) at $24.45 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: AKTX trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 47.3); meanwhile PRTO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 22.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
AKTX leads the Growth & Scale pillar: AKTX posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with PRTO at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, AKTX generates N/A in USD-normalized revenue versus N/A for PRTO. In operating R&D and SG&A reinvestment, AKTX deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for PRTO.
AKTX and PRTO trade at balanced relative valuation multiples. AKTX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas PRTO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AKTX (-146.3% ROE) versus PRTO (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, AKTX carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (77.35β · 143% Vol realized risk). By comparison, PRTO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.89β · 21% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.